A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare EpiCept™ NP-1 Topical Cream (2% ketamine / 4%
amitriptyline) vs. Oral Gabapentin in the treatment of Postherpetic Neuralgia (PHN)
Phase:
Phase 2
Details
Lead Sponsor:
EpiCept Corporation
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Gabapentin gamma-Aminobutyric Acid Ketamine